from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3444c/esxT

LFCtreatmentdescriptionclass of inhibitor

0.460

Amikacinug/mL Amikacintranslation

1.476

Cap5-10ug/mL Capreomycintranslation

0.918

Rox10-50 ug/mL Roxithromycintranslation

0.139

SM2-5 ug/mL Streptomycintranslation

0.685

Tet5-10 ug/mL Tetracyclinetranslation

0.911

Rif0.2-5ug/mL Rifampicintranscription

0.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.523

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.272

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.191

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.776

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.002

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.179

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.120

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.143

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.748

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.537

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.951

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.583

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.671

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.027

Nigericin50 uM Nigericinrespiration

-0.602

TRC10-150 ug/mL Triclosanrespiration

-0.665

TRZ10-25 ug/mL Thioridazinerespiration

0.751

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.766

menadione6-10 ug/mL Menadionerespiration

-0.224

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.095

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.396

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.041

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.199

NRP_1Non-replicating persistence stage 1dosRassociated

-0.192

Amp0.2mg/mL AmpicillincellWall

-0.124

Cephalexin20-100 ug/mL CephalexincellWall

0.663

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.057

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.058

EMB10-20 ug/mL EthambutolcellWall

-0.500

Eta12-40 ug/mL EthionamidecellWall

-0.193

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.452

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.021

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.692

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.500

BZA0.12 mg/mL BenzamidearomaticAmides

0.314

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.527

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.110

H2O24 mM hydrogen peroxideDNAdamaging

0.155

Levo10 ug/mL LevofloxacinDNAdamaging

0.577

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.449

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.075

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.454

UVUV-irradiationDNAdamaging

0.447

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.353

Antimycin12.5-50 ug/mL Antimycin A?

-0.050

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.954

PA_110-50 ug/mL Antitubercular compound PA-1?

1.426

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.015

PA8240.2-2 ug/mL PA-824?

-0.836

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.706

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.429

Verapamil50 uM Verapamil?

-0.482

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.433

methoxatin10-20 ug/mL Methoxatin?